Pain and treatment
toxicity show up in sleep
and HRV first.
Between infusions, nobody is watching. Ziva tracks HRV, sleep, resting heart rate, hydration and symptom burden every day, so your team sees rising toxicity, dehydration or a missed oral dose before it becomes an urgent call - or a preventable ED visit.
HIPAA compliant · Wearable insight + connected vitals devices · Infusion & oral-regimen protocols · CCM eligible
The days between infusions
are where toxicity builds.
Pain, nausea, fatigue and dehydration don't wait for the next appointment - they accumulate over days the care team can't see, and often surface first as a physiological pattern rather than a phone call.
A daily recovery record
for every patient in treatment.
Each patient has a daily point of contact and a daily physiological record, from day one of cycle one through survivorship.
Ziva never adjusts or recommends chemotherapy dosing - it gives your team the daily evidence to make that decision themselves, faster.
What Ziva does
for an oncology practice.
Objective daily recovery signal plus subjective daily symptoms plus adherence - the three inputs that determine whether toxicity is caught in clinic or in the ED.
Outcomes that matter
during active treatment.
Earlier detection changes the setting of care - a phone call and oral rehydration instead of an urgent infusion-center visit.
Directional framing based on Ziva's platform capabilities; actual results depend on panel size and payer mix.
From enrollment
to escalation - Ziva runs every step.
No new staff, no parallel system to learn. Your team sees the alert queue and the chart - Ziva runs everything in between.
Continuous contact that
changed the outcome.
Cancer care rarely stands alone.
Many oncology patients carry comorbid conditions Ziva already runs protocols for, all on the same record.
CCM is the primary fit —
RPM applies to connected vitals only.
RPM CPT codes require an FDA-defined medical device that transmits automatically - a connected scale, BP cuff or pulse oximeter. HRV and sleep from a consumer wearable inform Isabella's clinical picture but are not themselves billable under RPM. Most patients in active treatment do meet CCM's two-chronic-condition threshold, and many practices also layer Principal Illness Navigation time for the cancer diagnosis - confirm current codes and eligibility with your billing team.
Start with your
active infusion cohort.
Most oncology practices begin with patients in active treatment on emetogenic or high-toxicity regimens, then expand into oral-regimen and survivorship monitoring.
Built for healthcare.
Trusted by clinical teams.
Ziva was designed from the ground up for clinical environments - not adapted from a consumer app. Every data flow, access control, and integration meets the standards your compliance team requires.